Find latest healthcare news from every corner of the globe at Reuters.com, your online source for breaking international news coverage.

A blockbuster drug is a best-selling medication earning over $1 billion annually. Learn about them and how they revolutionize ...

BioMarin’s Voxzogo (vosoritide) won FDA approval in paediatric achondroplasia in November 2021 and secured a label extension ...

Hong Kong-listed Sino Biopharmaceutical said on Wednesday its unit has ​signed an exclusive global licensing deal ‌with ...

After the weight-loss drug boom, and with generics closing in, Big Pharma are gearing up for the next game-changer.

Chinese pharmaceutical companies that as a group chalked up record outbound licensing agreements with international industry ...

Telix reported FY2025 revenue of $804M, up 56% YoY, with Precision Portfolio products Illuccix and Gozellix contributing $622M. Read why TLX stock is a Buy.

FDA to incentivize quick reviews; Generate Biomedicines raises $400M in IPO; No­var­tis, Take­da agree to en­ter third round of Medicare drug price ne­go­ti­a­tions.

The capsules, a thalidomide analogue, are indicated for the treatment of adult patients with multiple myeloma who have received at least two prior therapies including lenalidomide and a proteasome ...

Following an extensive Middle East military build-up by the U.S. in recent weeks, the U.S. and Israel on Feb. 28 launched attacks across Iran. In response, Iran launched retaliatory attacks on Israel, ...

Indian pharmaceutical exports, including generic drugs, are unlikely to be affected by US President Donald Trump's recent announcement of 100 per cent tariffs on “any branded or patented" drugs ...